Dopamine D<sub>1</sub>/D<sub>5</sub> Receptor Antagonists with Improved Pharmacokinetics: Design, Synthesis, and Biological Evaluation of Phenol Bioisosteric Analogues of Benzazepine D<sub>1</sub>/D<sub>5</sub> Antagonists
Wen‐Lian Wu, Jean E. Lachowicz, Michelle Smith(The University of Queensland), William J. Greenlee, Richard Spring, Hongtao Zhang(Chinese Academy of Sciences), Duane A. Burnett(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ahmad Fawzi, Leonard Favreau(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 94
Related Papers
National Survey of Drug-Resistant Tuberculosis in China
|New England Journal of Medicine|2012|649
ErbB receptors: from oncogenes to targeted cancer therapies
|Journal of Clinical Investigation|2007|578
Transcriptional regulation of the rat NAD(P)H:quinone reductase gene
|Journal of Biological Chemistry|1991|500
Advances in clinical immunotherapy for gastric cancer
|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2021|435
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition
|Journal of Pharmacology and Experimental Therapeutics|2015|336